Terri L Butler

Title: Terri L Butler: Innovator in Cardiovascular Function and Controlled Release Formulations

Introduction:

Terri L Butler, a seasoned inventor based in Kirkland, WA, is a brilliant mind in the field of health and pharmaceutical innovations. With a strong focus on cardiovascular function and controlled release formulations, Butler has made significant contributions to improving human health. This article will delve into Butler's latest patents, career highlights, collaborations, and overall impact in the industry.

Latest Patents:

Butler's latest patents showcase a keen interest in supplementing the diets of individuals with cardiovascular disease and developing controlled release formulations for probiotics. Let's take a closer look at these notable inventions:

1. Compositions and Methods for Improving Cardiovascular Function:

This patent presents methods for supplementing the diet of subjects suffering from cardiovascular disease. Butler's invention involves long-term administration of D-Ribose, either alone or in combination with vasodilators. The aim is to improve or maintain the diastolic or systolic function of the subjects, thereby contributing to their overall cardiovascular health.

2. Delivery System for Biological Component:

In this patent, Butler focused on developing a controlled release formulation for a probiotic. The specially formulated monolithic tablet, designed for oral delivery to the intestinal system, contains a hydrophilic agent, an electrolytic agent, and a polysaccharide. The probiotic featured in this invention is lactic acid bacteria, known for its potential health benefits.

Career Highlights:

Throughout Butler's remarkable career, several companies have had the privilege of benefitting from their innovative abilities. Notable highlights include:

1. Bio-Energy Corporation (renamed BioEnergy Systems Corporation):

Butler made significant contributions to the field of renewable energy solutions during their time at Bio-Energy Corporation. Their work focused on developing novel approaches to biofuels and clean energy technologies, setting the stage for sustainable energy development.

2. Nutraceutix, Inc.:

Butler's expertise also extended into the realm of nutraceuticals at Nutraceutix, Inc. This company is renowned for its range of formulation and manufacturing capabilities, particularly in the field of probiotics and controlled release formulations.

Collaborations:

Innovation often flourishes through collaborations, and Butler's work is no exception. Noteworthy collaborations include:

1. John St Cyr:

Working alongside John St Cyr, Butler explored novel techniques for improving cardiovascular function. Their collaboration resulted in significant advancements in the field and solidified their positions as leading innovators in this specific domain.

2. Clarence A Johnson:

Collaborating closely with Clarence A Johnson, Butler contributed to the development of cutting-edge controlled release formulations for biological components. This collaboration showcased their shared dedication to enhancing drug delivery systems, ultimately benefiting patients worldwide.

Conclusion:

Terri L Butler's exceptional innovation in cardiovascular function and controlled release formulations has made a lasting impact on the health and pharmaceutical industries. Their patents offer hope for individuals with cardiovascular disease and provide new avenues for improving drug delivery systems. Through collaborations and contributions to esteemed organizations, Butler has cemented their place as an accomplished inventor and an invaluable asset to the field of innovations and patents.